Evaluating Rivaroxaban for Nonvalvular Atrial Fibrillation - Regulatory Considerations

被引：31

作者：

Fleming, Thomas R. ^{[1
]}

Emerson, Scott S. ^{[1
]}

机构：

[1] Univ Washington, Dept Biostat, Seattle, WA 98195 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 365卷 / 17期

关键词：

D O I：

10.1056/NEJMp1110639

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1557 / 1559

页数：3

共 4 条

[1] Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].

Connolly, Stuart J. ;

Ezekowitz, Michael D. ;

Yusuf, Salim ;

Eikelboom, John ;

Oldgren, Jonas ;

Parekh, Amit ;

Pogue, Janice ;

Reilly, Paul A. ;

Themeles, Ellison ;

Varrone, Jeanne ;

Wang, Susan ;

Alings, Marco ;

Xavier, Denis ;

Zhu, Jun ;

Diaz, Rafael ;

Lewis, Basil S. ;

Darius, Harald ;

Diener, Hans-Christoph ;

Joyner, Campbell D. ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151

[2] Some essential considerations in the design and conduct of non-inferiority trials [J].

Fleming, Thomas R. ;

Odem-Davis, Katherine ;

Rothmann, Mark D. ;

Shen, Yuan Li .

CLINICAL TRIALS, 2011, 8 (04) :432-439

[3] Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation [J].

Patel, Manesh R. ;

Mahaffey, Kenneth W. ;

Garg, Jyotsna ;

Pan, Guohua ;

Singer, Daniel E. ;

Hacke, Werner ;

Breithardt, Guenter ;

Halperin, Jonathan L. ;

Hankey, Graeme J. ;

Piccini, Jonathan P. ;

Becker, Richard C. ;

Nessel, Christopher C. ;

Paolini, John F. ;

Berkowitz, Scott D. ;

Fox, Keith A. A. ;

Califf, Robert M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (10) :883-891

[4]

US Government Printing Office, 1995, FED REGISTER, V60, P39180

← 1 →